Landscapes / Targets
FcRn
3 drugs act on FcRn, in 32 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs3
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | Mar 2027Phase 2/3 trial completes | |||
| Next date | Mar 2027 · Phase 2/3 trial completes | ||||
| Also tested for | Generalized Myasthenia Gravis, gMG and 32 more | ||||
| Open drug page | |||||
Monoclonal antibody |
Approved | 6 May 2027Phase 3 trial completes | |||
| How it works | An antibody | ||||
| Next date | 6 May 2027 · Phase 3 trial completes | ||||
| Also tested for | Ocular Myasthenia Gravis, Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (MOGAD) and 2 more | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 3 | May 2027Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | May 2027 · Phase 2 trial completes | ||||
| Also tested for | Graves' Disease, Rheumatoid Arthritis and 5 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 3 of 3 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026